Kew J[au] - Search Results

Year	Number of Results
1955	1
1963	2
1990	1
1992	1
1993	4
1994	5
1995	3
1996	5
1997	6
1998	15
1999	10
2000	14
2001	7
2002	9
2003	8
2004	6
2005	5
2006	5
2007	5
2008	9
2009	7
2010	4
2011	7
2012	3
2013	1
2016	2
2017	1
2020	1
2022	0

1

Alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators.

Lightfoot AP, Kew JN, Skidmore J. Lightfoot AP, et al. Among authors: kew jn. Prog Med Chem. 2008;46:131-71. doi: 10.1016/S0079-6468(07)00003-3. Prog Med Chem. 2008. PMID: 18381125 Review. No abstract available.

2

An unusual skin rash in a person with type 1 diabetes.

Kew JL, Bain SC. Kew JL, et al. Diabet Med. 2020 Sep;37(9):1607-1608. doi: 10.1111/dme.14263. Epub 2020 Feb 27. Diabet Med. 2020. PMID: 32020665 No abstract available.

3

Ionotropic and metabotropic glutamate receptor structure and pharmacology.

Kew JN, Kemp JA. Kew JN, et al. Psychopharmacology (Berl). 2005 Apr;179(1):4-29. doi: 10.1007/s00213-005-2200-z. Epub 2005 Feb 25. Psychopharmacology (Berl). 2005. PMID: 15731895 Review.

4

Investigation of the H(+)-myo-inositol transporter (HMIT) as a neuronal regulator of phosphoinositide signalling.

Di Daniel E, Kew JN, Maycox PR. Di Daniel E, et al. Among authors: kew jn. Biochem Soc Trans. 2009 Oct;37(Pt 5):1139-43. doi: 10.1042/BST0371139. Biochem Soc Trans. 2009. PMID: 19754467 Review.

5

Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.

Mony L, Kew JN, Gunthorpe MJ, Paoletti P. Mony L, et al. Among authors: kew jn. Br J Pharmacol. 2009 Aug;157(8):1301-17. doi: 10.1111/j.1476-5381.2009.00304.x. Epub 2009 Jul 8. Br J Pharmacol. 2009. PMID: 19594762 Free PMC article. Review.

6

Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR.

Fricker AC, Mok MH, de la Flor R, Shah AJ, Woolley M, Dawson LA, Kew JN. Fricker AC, et al. Among authors: kew jn. Neuropharmacology. 2009 May-Jun;56(6-7):1060-7. doi: 10.1016/j.neuropharm.2009.03.002. Epub 2009 Mar 12. Neuropharmacology. 2009. PMID: 19285517

7

Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential.

Kew JN. Kew JN. Pharmacol Ther. 2004 Dec;104(3):233-44. doi: 10.1016/j.pharmthera.2004.08.010. Pharmacol Ther. 2004. PMID: 15556676 Review.

8

Developmental changes in NMDA receptor glycine affinity and ifenprodil sensitivity reveal three distinct populations of NMDA receptors in individual rat cortical neurons.

Kew JN, Richards JG, Mutel V, Kemp JA. Kew JN, et al. J Neurosci. 1998 Mar 15;18(6):1935-43. doi: 10.1523/JNEUROSCI.18-06-01935.1998. J Neurosci. 1998. PMID: 9482779 Free PMC article. Review.

9

CT and MR imaging appearances of an extraosseous calcifying epithelial odontogenic tumor (Pindborg tumor).

Ching AS, Pak MW, Kew J, Metreweli C. Ching AS, et al. Among authors: kew j. AJNR Am J Neuroradiol. 2000 Feb;21(2):343-5. AJNR Am J Neuroradiol. 2000. PMID: 10696021 Free PMC article. Review.

10

A novel series of benzimidazole NR2B-selective NMDA receptor antagonists.

Davies DJ, Crowe M, Lucas N, Quinn J, Miller DD, Pritchard S, Grose D, Bettini E, Calcinaghi N, Virginio C, Abberley L, Goldsmith P, Michel AD, Chessell IP, Kew JN, Miller ND, Gunthorpe MJ. Davies DJ, et al. Among authors: kew jn. Bioorg Med Chem Lett. 2012 Apr 1;22(7):2620-3. doi: 10.1016/j.bmcl.2012.01.108. Epub 2012 Feb 6. Bioorg Med Chem Lett. 2012. PMID: 22366657

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results